T3 - Technion Technology Transfer - Technion R&D Foundation (TRDF) Ltd.

t3.technion.ac.il ; www.trdf.co.il/eng/About_T3

Technology Transfer Company

Tech Verticals Preferences

Aerospace, AgriTech, Artificial Intelligence, Automation, Automotive, Biotechnology, Chemistry, Construction Tech, Cyber Security, Data Analytics, Defense Tech, DevOps, Diagnostics, Digital Health, Electrical Engineering, Electro Optics, Energy Tech, Enterprise Applications, FoodTech, Image & Audio, Industrial Technologies, Industry 4.0, Information Technology, Materials, Medical Devices, MedTech, Military, Mobility Tech, Nanotechnology, Networking Infrastructure, Pharmaceuticals, Physics, Quantum Technology, Search Engine, Security, Software Technologies, Sustainability, WaterTech, Wireless Applications, Wireless Infrastructure

General Data

Established	1985
Current Active Portfolio Companies:	108
Reg. Number:	abCDe

DESCRIPTION

T3 is the technology transfer office of Technion – Israel Institute of Technology. As part of the Technion R&D Foundation Ltd. (TRDF), T3’s mission is to cultivate Technion’s human capital and unparalleled wealth of knowledge, linking academy and industry to commercialize and democratize sustainable, high-impact technologies for the future.

To achieve this, T3 nurtures promising research and talented researchers to leap from the lab to the field, by assisting the researchers to identify commercially viable technologies and obtain legal protection for the intellectual property, and connecting them with promising companies and entrepreneurs so that together, they can change the way we live, learn, work and interact.

T3 offers acceleration and maturation programs based on industry funded research and applied research funds, as well as investments in existing or new start-up companies from early stages to Round B.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Technion - Israel Institute of Technology
	Accelerator	Technion T-Hub	Technion - Israel Institute of Technology
	Division	Rappaport Family Institute for Research in the Medical Sciences (cc)	Technion - Israel Institute of Technology
49605D8A-A8BA-EE11-B812-00505695CD29	Investment Arm	Technion Investment Opportunities Fund LP (TIOF)	Technion - Israel Institute of Technology
85A5DB50-207A-E111-AC59-00155D32A403	Investment Arm	T3 - Technion Technology Transfer - Technion R&D Foundation (TRDF) Ltd.	Technion - Israel Institute of Technology
FA72D3A3-493A-E311-8237-00237DE91982	Investment Arm	AMIT - Alfred Mann Institute at the Technion Ltd.	Technion - Israel Institute of Technology
A1A54AFB-E941-E611-BD22-80C16E7D3630	Spin-off	FeelIT Technologies Ltd.	Technion - Israel Institute of Technology
FAB15335-9980-E511-BD22-80C16E7D3630	Subsidiary	The Technion T-Factor	Technion - Israel Institute of Technology
90A5DB50-207A-E111-AC59-00155D32A403	Investment Arm	BioRap Technologies Ltd.	Rappaport Family Institute for Research in the Medical Sciences (cc)	Ceased
7186ACDD-1929-E411-A2AF-80C16E7D3630	Subsidiary	Technion's BizTec Program	Technion T-Hub

CONTACT INFO

Expand / Collapse All

Main Address: Haifa, Israel

Address	Technion City, Malat Building, 5th floor
City	Haifa
Country	Israel
Zip	3200002

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Ms. Rona Samler	General Manager & CBO	Ramot at TAU (VP, BD Physical Sciences)
Ms. Ilana Shalev	Director of Operations and Project Management
Mr. Motti Koren	Director of Business Development, Life Sciences, AI/ML	Neural Flow (VP Business development)
Dr. Mor Goldfeder	Director of Business Development, Life Sciences
Ms. Shikma Litmanovitz-Tsury	Director of BD, Physical Sciences
Dr. Arkadiy Morgenshtein	Director of Business Development, ICT
Dr. Shulamit Hirsch	Head of Intellectual Property	Ramot at TAU (VP, Intellectual Property)
Ms. Tal Noy-Cohen	Legal Counsel, License	Goldsobel & Kirshen (Partner)
Mr. Roy Avneri	Legal Counsel, Corporate

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2024

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Mar. 01, 2023

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Mar. 01, 2022

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Dec. 02, 2018

abCDe

Co-op with Primus Power (Hayward, California).

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Bi-National Fund	abCDe

Preferences

Type of Financing	Equity,In-Licensing,Joint R&D
Stage Preferences	Initial Revenues,R&D,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Biomed

20%

Enterprise Software & Infrastructure

19%

Medical Devices

19%

Agritech

10%

Hardware & Industrial

Digital Health

Energy

Cleantech

Consumer-Oriented Software

Semiconductors

Network Infrastructure

	PORTFOLIO COMPANIES

Current Portfolio Companies (108)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Accellta

Biomed

First Round	01/01/2014	N/A	$4m
Seed	01/11/2012	N/A	N/A

AD Knight

Ent. SW

Seed - Extended

01/04/2021

N/A

Aleph Farms

Agri

Seed

01/07/2017

N/A

$2.4m

Amplio

Ent. SW

Seed - Extended

01/10/2017

N/A

$0.75m

Anydish

Dig. Health

First Round

01/04/2018

N/A

ARTsys360

Network Infra.

Bridge	01/04/2021	N/A	$0.95m
Second Round	01/04/2017	N/A	$0.8m
First Round	01/04/2016	N/A	$1.5m
Seed	28/10/2014	N/A	$0.45m

Autobrains

Ent. SW

Third Round

01/11/2021

N/A

$101m

Barcode Nanotech

Biomed

Seed

01/02/2017

N/A

$0.9m

BeeHero

Agri

Seed

01/06/2018

N/A

$3m

Benevira

Biomed

Seed

01/04/2021

N/A

BioFishency

Agri

R&D Grant

01/06/2021

N/A

BiotaX

Biomed

Seed

30/05/2021

N/A

$2.4m

BlueCircle

Agri

First Round

01/10/2018

N/A

CannaSoul

Biomed

Seed - Extended

01/04/2019

N/A

CAPS Medical

First Round	29/07/2020	N/A	$3.5m
Seed	01/06/2018	N/A	N/A

Cathalert

Seed

01/03/2023

N/A

Ceal

Energy

Non-Equity Assistance

01/05/2024

N/A

Civ Robotics

$Civ Robotics is an autonomous surveying solution for civil engineering and infrastructure projects. The company’s flagship product, CivDot, is an unmanned ground vehicle (UGV) which marks thousands of coordinates per day precisely and efficiently for large construction projects, while empowering workforces faced with labor shortages and subsequent delays. Through the press of a button and in a fraction of the time, Civ Robotics autonomous systems are revolutionizing projects, including solar farms, roadways, data centers, power plants, industrial development and large infrastructure.$

Ent. SW

Seed - Extended

27/08/2019

N/A

$1.7m

Colospan

Seed

01/12/2010

N/A

$0.8m

Contilt

Ent. SW

Seed

01/02/2022

N/A

$20m

CoreFlow

HW & Indust.

Seed

01/07/1999

N/A

$0.7m

Cortica

Ent. SW

Seed

01/10/2008

N/A

$4.5m

Cytoreason

Dig. Health

First Round

01/07/2018

N/A

$0.13m

Diagnostic Robotics

Dig. Health

First Round

03/10/2019

N/A

$24m

DistanSea

Agri

Seed

01/06/2025

N/A

DLRob

Deep Learning Robotics’ patent-pending self-learning robotic controller can cost effectively automate tasks that would not be feasible with conventional robotic solutions. It is revolutionizing how robots are programmed and operated in structured and unstructured environments. Manufacturers whose production processes involve many small and diverse batches can now benefit from the productivity and other advantages of robotic automation. Companies of all sizes across a wide range of industries will be able to compete better and thrive in today’s global economy.

HW & Indust.

Seed

01/01/2016

N/A

$0.55m

ElectricAlgae

Energy

Seed

22/02/2024

N/A

Eloxx

Biomed

First Round

21/11/2013

N/A

$8.5m

Encer

Biomed

Seed

01/03/2020

N/A

FeelIT

HW & Indust.

First Round - Extended	14/01/2021	N/A	$5m
First Round	28/07/2019	N/A	$1.5m
Seed	01/01/2017	N/A	$2m

Firefly Neuroscience

Firefly is an Artificial Intelligence (AI) company developing innovative solutions that improve brain health outcomes for patients with neurological and mental disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA™) technology revolutionizes diagnostic and treatment monitoring methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has built a comprehensive database of brain wave tests, securing patent protection, and achieving FDA clearance. The Company is now launching BNA™ commercially, targeting pharmaceutical companies engaged in drug research and clinical trials, as well as medical practitioners for clinical use.

Seed

01/03/2006

N/A

$3.2m

Fluid Medical

Seed

03/12/2020

N/A

Genopore

Biomed

Seed

27/02/2023

N/A

GreenQ

Cln.

Bridge

01/04/2017

N/A

$0.1m

H2OLL

Cln.

Seed

01/10/2020

N/A

H2Pro

Energy

Seed

01/09/2019

N/A

$5m

Harnessing Stress-Induced Proteasome Dynamics to...

Biomed

Seed

02/01/2021

N/A

Igentify

Dig. Health

Seed

01/12/2016

N/A

$0.5m

iRen Medical

iRen is a developer of a kidney dialysis system, designed to deliver peritoneal dialysis treatment at home. The company's dialysis device is a portable, lightweight, automatic system that offers easy setup and maintenance, enabling patients to perform peritoneal dialysis painlessly at home without having to move to centers, enabling doctors to reduce treatment time, healthcare costs and infection rates.

Seed

01/12/2016

N/A

$0.815m

Jether Energy

Ent. SW

First Round

01/01/2017

N/A

Lamu

HW & Indust.

Seed

01/01/2020

N/A

LAVA Energy

LAVA is an isothermal thermodynamic cycle, designed to maximize efficiency in converting heat to electricity and electricity to heat. Unlike traditional cycles that suffer from energy losses due to temperature fluctuations, LAVA operates at a near-constant temperature, significantly improving performance and reliability.

LAVA Powers Two Products:
LAVA Heat Engine
Converts waste heat and geothermal energy into electricity.
Achieves 30% higher efficiency than competing technologies.
Ideal for industrial waste heat recovery, geothermal power, and liquid-cooled data centers.

LAVA Heat Pump
Provides heating and cooling with a 30%-50% better COP than existing solutions.
Replaces gas boilers with a high-efficiency alternative.
Can be used for industrial heating, district heating, and data center cooling.

Why LAVA?
Disruptive Efficiency – The first isothermal cycle, reducing energy losses and boosting performance.
Versatile Applications – Enables clean energy solutions across industries.
Scalability & Cost-Effectiveness – Designed for large-scale deployment with competitive manufacturing costs.

LAVA is setting a new standard for thermal energy conversion, redefining the future of clean power and efficient heating & cooling.

Energy

Seed - Extended

15/12/2022

N/A

$12.5m

Leadspace

Ent. SW

Seed - Extended

15/12/2007

N/A

$1m

Levron

Seed

24/08/2021

N/A

$2.1m

LiteBC

Seed

01/11/2019

N/A

$0.1m

Lumana

Ent. SW

Seed

01/12/2023

N/A

$24m

Lydus

Biomed

Seed

01/01/2017

N/A

$2.1m

Lynxight

Ent. SW

Seed

08/05/2018

N/A

$0.1m

Mana.Bio

Biomed

Seed

18/10/2021

N/A

$5m

Mat Xcelertor

Ent. SW

Seed

01/03/2023

N/A

Mealiways

HW & Indust.

Seed

20/09/2022

N/A

Meatafora

HW & Indust.

First Round

06/03/2023

N/A

$5m

Medic Vision

Seed

01/06/2006

N/A

$0.1m

MetoMotion

Agri

First Round

31/07/2019

N/A

$1.5m

Microbot

Seed

01/11/2010

N/A

$0.5m

Mobi

CO SW

Seed - Extended	31/07/2019	N/A	N/A
Seed	23/08/2017	N/A	$3m

Moebius Medical

Biomed

Seed

01/09/2008

N/A

$0.8m

Momentis

Seed

01/10/2013

N/A

$1m

MU-NAV

Ent. SW

Seed

01/04/2025

N/A

Nanit

CO SW

Seed

15/06/2016

N/A

$6.6m

NanoGhost

Biomed

Seed

24/12/2019

N/A

$5m

NanoScent

Energy

Seed

01/05/2017

N/A

$2m

Nanose

Biomed

Seed

22/06/2020

N/A

NanoSpun

Cln.

Seed

01/10/2010

N/A

NanoSynex

Biomed

First Round

01/09/2018

N/A

$14m

Neshima

Seed

01/11/2018

N/A

Nevia Bio

Dig. Health

First Round

08/04/2021

N/A

$0.9m

NewRocket

HW & Indust.

Seed

01/10/2014

N/A

$0.7m

NGT Healthcare II

N/A

Investment in Fund

22/02/2022

N/A

$92m

NovaSight

Seed

01/11/2016

N/A

$2m

Nurami Medical

Nurami's proprietary, electrospun-based platform technology enables the creation of an innovative category of bio surgical implants to seal and heal wounds effectively. It addresses complications associated with current soft tissue implants, such as dangerous leaks, and promotes healthy tissue formation, such as Dura repair, as well as other tissue recovery processes.

First Round

20/12/2016

N/A

$0.65m

Nurexone

Biomed

Seed

01/06/2020

N/A

OncoHost

Biomed

Second Round

19/01/2021

N/A

$8m

OPCloud

Ent. SW

Seed

01/03/2022

$0.1m

Pickommerce

HW & Indust.

Seed

01/01/2021

N/A

Pluri

Biomed

Seed

01/10/2002

N/A

$1.5m

PMT

PTM harnesses novel science to transform industrial waste streams into powerful revenue sources. The company's proprietary extraction technology developed in partnership with the Technion Institute and Duke University efficiently recovers high-value metals from phosphate mining and geothermal energy processes.

Cln.

Seed

01/07/2025

N/A

Promus

N/A

Seed

01/02/2025

N/A

PsygaBio

Biomed

Seed

08/06/2021

N/A

Qedma

Ent. SW

Seed

20/10/2020

N/A

$4.67m

QuamCore

Semicon.

Seed - Extended

12/03/2025

N/A

$8m

Regentis

Fourth Round	07/02/2016	N/A	$15m
Seed	25/10/2004	N/A	$1m

Regulus Cyber

Ent. SW

Second Round	18/05/2020	N/A	$4m
First Round	01/05/2018	N/A	$5.1m

Remedy Cell

Biomed

Seed

18/12/2022

N/A

ReSight

Ent. SW

Seed

18/05/2017

N/A

$0.1m

Resugar

Agri

First Round

29/03/2022

N/A

$3m

RNAWay

Agri

Seed

24/01/2022

N/A

Sanoculis

Seed

01/06/2012

N/A

SeeTrue AI

SeeTrue is a global AI software solution leader for security screening. It provides a secure, rapid, and streamlined security screening process by seamlessly integrating with any existing X-ray and CT scanners at airports, seaports, urban security checkpoints, customs, and shipment facilities. SeeTrue enhances operational efficiency and sets a fast, secure, and consistent screening. The software detects explosives and prohibited items in real-time, such as guns, knives, liquids, electronics, and other items that may be considered restricted in all types of baggage and parcels. Founded in 2018, SeeTrue’s solution has been globally implemented over the past 5 years, successfully intercepting more than a million prohibited items from boarding planes, entering mass transit, or jeopardizing public safety through parcels arriving in countries.
SeeTrue was created to revolutionize the current security screening process, addressing the challenges of passenger throughput, experience, security, and cost with a new Artificial Intelligence approach.

Ent. SW

Seed

03/02/2020

N/A

$2.9m

Sleep Sense

Seed

01/01/1993

N/A

SleepAI

Dig. Health

Seed

01/12/2024

N/A

$0.85m

Sofea

N/A

Seed

01/08/2020

N/A

Speedata

Semicon.

Seed

01/08/2019

N/A

$15m

Spinflex

HW & Indust.

Seed

01/10/2020

N/A

Spinodal

Seed

16/10/2023

N/A

$2.1m

Tabnine

Ent. SW

Seed

01/01/2017

N/A

$0.55m

TechsoMed

Seed

01/10/2013

N/A

ThermagiX

Energy

Seed

01/10/2023

N/A

$3m

TODOS

Agri

First Round	01/06/2018	N/A	N/A
Seed	24/07/2012	N/A	N/A

Tripod

Biomed

Seed

01/11/2021

N/A

UB Therapeutics

Biomed

Seed

01/02/2023

N/A

$2.1m

Ultrasenic

Semicon.

Bridge

01/11/2019

N/A

$0.1m

Ultrasight

Biomed

First Round

19/03/2019

N/A

$2m

Verifyoo

Ent. SW

Seed

01/01/2015

N/A

ViAqua

Agri

Second Round	09/06/2021	N/A	$4.3m
Seed	01/09/2014	N/A	$0.6m

Vigor

Seed

01/12/2014

N/A

VineSight

Ent. SW

Seed

01/12/2019

N/A

Voiceitt

CO SW

Seed

01/05/2012

N/A

$0.04m

Exits (26)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij	Acquired	14/10/2015	abCDe
abC Defghij	Acquired	05/09/2018	abCDe
abC Defghij	Acquired	08/08/2019	abCDe	The transaction is expected to close in the Q4/2019, subject to approval by Corindus stockholders, the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, and the satisfaction of other customary closing conditions.
abC Defghij	Acquired	25/04/2024	abCDe
abC Defghij	Acquired	22/03/2017	abCDe
abC Defghij	Acquired	30/06/2008	abCDe
abC Defghij	Acquired	03/10/2019	abCDe	Including $20m of contingent consideration related to certain technical and revenue milestones that were achieved.
abC Defghij	Acquired	01/01/2018	abCDe
abC Defghij	Acquired	15/01/2012	abCDe
abC Defghij	Acquired	18/12/2021	abCDe
abC Defghij	IPO	09/03/2007	abCDe	Stocks and options.
abC Defghij	IPO	12/09/2014	abCDe
abC Defghij	Acquired	21/09/2018	abCDe	In cash. The acquisition is expected to close in 01/2019, subject to customary closing conditions including receipt of regulatory clearances and approval by Mazor's shareholders.
abC Defghij	IPO	23/08/2007	abCDe
abC Defghij	Acquired	01/12/2025	abCDe	$59m in upfront cash, plus up to $90m in variable contingent consideration tied to future commercial performance and regulatory approvals.
abC Defghij	IPO	02/10/2015	abCDe
abC Defghij	Acquired	01/12/2005	abCDe	Optiguide's CEO bought it back in 04/2007.
abC Defghij	Acquired	04/01/2022	abCDe
abC Defghij	Acquired	03/05/2021	abCDe
abC Defghij	Acquired	19/12/2018	abCDe
abC Defghij	Acquired	24/04/2013	abCDe	In shares.
abC Defghij	Acquired	10/09/2024	abCDe
abC Defghij	Acquired	31/01/2019	abCDe
abC Defghij	Acquired	03/08/2022	abCDe
abC Defghij	Acquired	05/11/2025	abCDe	$125m in cash, $100m in shares.
abC Defghij	Acquired	12/02/2020	abCDe	An additional $56m were dependent on milestones that ultimately did not materialize.

Historic Portfolio (45)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

AgadaTech

Ceased to Operate

Agri

Seed

01/03/2020

N/A

Avraham Pharmaceuticals

Ceased to Operate

Biomed

Fourth Round	25/02/2016	N/A	$4m
Third Round	17/09/2014	N/A	$4.5m
Second Round	21/02/2013	N/A	$5.7m
Seed	14/04/2010	N/A	$9m

Bactusense

Ceased to Operate

Biomed

Seed

01/05/2016

N/A

$0.55m

BEE

Ceased to Operate

HW & Indust.

Seed

01/12/1994

N/A

$0.5m

CartiCure

Suspendeed Operations

Biomed

Seed

10/04/2006

N/A

$0.15m

CaVnox

Ceased to Operate

Biomed

Seed - Extended

11/07/2022

N/A

CorrelSense

Ceased to Operate

Ent. SW

Seed

01/03/2005

N/A

$1.3m

fitto

Ceased to Operate

Network Infra.

Seed

12/09/2017

N/A

$0.03m

GeneGrafts

Ceased to Operate

Seed

17/12/2003

N/A

$0.4m

GlueCell Medical

Ceased to Operate

Seed

01/02/2021

N/A

Hydro Industries

Ceased to Operate

Cln.

Seed

01/10/1997

N/A

InEnSto

Ceased to Operate

Energy

Seed

01/06/2017

N/A

$0.9m

InPlant

Ceased to Operate

Agri

Seed

01/05/2016

N/A

$0.47m

Kensee

Ceased to Operate

$Kensee provides first management information system for commercial real estate. Using their application, users get, in fraction of time, hundreds of reliable real estate data-points, market trends and signals directly to their fingertips. Kensee does it by automatically collecting real estate data from thousands of sources and organizing it using language processing and machine learning algorithms, so users could easily make data driven decisions and manage their real estate portfolio with unparalleled transparency.$

Ent. SW

Seed

06/06/2016

N/A

$1m

Magna Mater Medical

Ceased to Operate

Seed

25/11/2021

N/A

Maygia

Ceased to Operate

Energy

Seed

26/01/2020

N/A

MemTech

Ceased to Operate

Cln.

Seed

01/10/2010

N/A

$0.6m

Metabomed

Ceased to Operate

Biomed

Seed

27/11/2013

N/A

$3.4m

MPT

Ceased to Operate

Biomed

Seed

01/06/2013

N/A

$0.6m

NanoVation GS

Ceased to Operate

First Round	01/01/2017	N/A	N/A
Seed	01/01/2014	N/A	N/A

Naor

Ceased to Operate

Seed

01/07/2020

N/A

NexCV

Ceased to Operate

Ent. SW

Seed

01/04/2017

N/A

$0.1m

Nutrinia

Ceased to Operate

Biomed

Seed

21/09/2003

N/A

$0.1m

Olfaguard

Ceased to Operate

Agri

Seed

01/05/2016

N/A

$0.4m

OneCell Medical

Ceased to Operate

Biomed

Seed

01/06/2017

N/A

$2.1m

PatX

Ceased to Operate

Ent. SW

Bridge

01/11/2019

N/A

$0.1m

Pneumedicare

Ceased to Operate

Seed

17/04/2007

$0.04m

$0.6m

PuroW

Ceased to Operate

Cln.

Seed

01/06/2010

N/A

RenalSense

Ceased to Operate

First Round	31/12/2015	N/A	$4.5m
Seed	01/06/2010	N/A	$1.29m

RFISee

Ceased to Operate

Semicon.

Bridge

08/05/2018

N/A

$0.1m

SatSmart

Ceased to Operate

Network Infra.

Seed

01/07/1998

N/A

$0.5m

SBM

Ceased to Operate

Ent. SW

Seed

01/07/2010

N/A

Sentient Synthetics

Ceased to Operate

Dig. Health

Seed

01/09/2021

N/A

$0.25m

Skyrad

Ceased to Operate

Cln.

Seed

01/10/1997

N/A

Slender Medical

Ceased to Operate

Seed - Extended

01/10/2007

N/A

Space Plasmatics

Ceased to Operate

HW & Indust.

Seed

01/04/2021

N/A

Stem Cell Therapeutics

Ceased to Operate

Biomed

Seed

01/10/2004

N/A

Symbol Therapeutics

Ceased to Operate

Biomed

Seed

16/01/2022

N/A

$2.1m

Tamar Robotics

Ceased to Operate

First Round	17/06/2021	N/A	$10m
Seed	09/07/2019	$0.54m	$2.8m

Tehuti

Ceased to Operate

Semicon.

Seed

01/04/2002

N/A

$0.1m

TheWhollySee

Ceased to Operate

Ent. SW

Seed

01/02/2016

$0.05m

Varinel

Suspendeed Operations

Biomed

Seed

01/10/2003

N/A

Vayar

Ceased to Operate

CO SW

Seed

01/12/2007

N/A

$0.75m

WellToDo

Ceased to Operate

Cln.

First Round	01/01/2016	N/A	$0.7m
Seed	01/09/2012	N/A	$0.1m

XACT Robotics

Ceased to Operate

Seed

01/07/2013

N/A

Last Updated:	abCDe
IVC Number:	abCDe